The worldwide endoscopy equipment market will reach $ 35.73 billion in 2026 from an estimated $ 25.30 billion in 2021 at a CAGR of 6.3% over the foreseen period.
Key drivers for the expansion of this market include an escalating call for endoscopy, increased investments, funds and grants, an escalating number of hospitals, and increased investment in hospitals in endoscopy facilities and technological advancements. Endoscopy is minimally invasive and causes little or no pain to patients. It is also useful in treating mucosal disorders that arise within the gastrointestinal tract.
An endoscopy is a procedure that allows doctors or surgeons to look at the internal parts of the organ. The technique is employed for both diagnostic and therapeutic purposes. To perform an endoscopy, a specialized instrument called an endoscope is employed. Different types of endoscopes and the adoption of an endoscope depends on the affected body organ, for example, bronchoscopes are employed for problems related to the lungs, arthroscopes are preferred for problems associated with the joints, and many more. other. Endoscopic surgery is a type of minimally invasive surgery in which an endoscope is inserted into the body through small incisions to examine internal organs.
The escalating prevalence of chronic diseases, advances in endoscopy technology, and increased funding and reimbursement for endoscopic detection and treatment are driving the expansion of the worldwide endoscopy device market. Additionally, the growing popularity of minimally invasive surgery is also creating enormous potential for market expansion.
The high escalation in the prevalence of age-related diseases and the escalating call for endoscopy equipment in diagnostic and therapeutic procedures are factors driving the industry. The use of such devices in the diagnosis and treatment of multiple conditions is essential because it allows minimal intervention, resulting in a shorter recovery time. Compared to open surgeries, these procedures result in faster recovery and less trauma for patients. Therefore, minimally invasive surgical procedures are preferred over open/invasive surgeries and therefore the call for minimally invasive endoscopic devices is likely to increase in the coming years. The switch to minimally invasive surgeries can also be attributed to higher patient satisfaction, economic viability, a relatively shorter hospital stay, and a reduction in postoperative complications. Therefore, the call for minimally invasive endoscopic surgeries is predicted to increase in the coming years.
Infections and complications caused by endoscopy devices can hamper market expansion. The main reason for the decrease in endoscopy procedures during the COVID-19 pandemic was the decrease in the volume of patients in hospitals, due to the rescheduling and delay of procedures for safety reasons. Additionally, these delays occurred after a careful review of the patient's history and, where possible, healthcare providers have rescheduled endoscopic procedures to minimize the risk of COVID-19 exposure during hospital visits. All of these factors are also predicted to affect the endoscopy device market in the future.
The worldwide market for endoscopy devices is predicted to experience significant expansion during the foreseen period, due to technological advancements in endoscopes that can be employed for early detection of disease and the escalating prevalence rate of diseases requiring devices. endoscopy. Additionally, favorable FDA approvals and reimbursement policies for endoscopy devices in developed economies increase patients' preference for minimally invasive surgeries, shorter recovery times, and complications. Postoperative surgery is driving the expansion of the worldwide endoscopy device market. However, the shortage of qualified physicians and endoscopists and infections caused by some endoscopes are limiting market expansion. In contrast, unmet medical calls in developing countries should provide profitable opportunities for market expansion. The escalating prevalence of cancer and obesity and the introduction of bariatric endoscopic surgeries, due to the escalating trend of preventive health care, are key factors contributing to the expansion of this market.
In recent years, the market has witnessed several products recalls, mainly for reasons related to defects in the equipment manufacturing processes. Frequent product recalls represent a huge challenge for the expansion of the endoscopy equipment market, especially for the big players: Olympus had to recall four of its products in 2019.
Endoscopes accounted for the largest market share in 2020 and this segment is also predicted to grow at the highest CAGR during the foreseen period.
The GI endoscopy applications segment is predicted to occupy the majority of the market and grow at the highest CAGR during the foreseen period. The increase in the geriatric population, the improvement of the healthcare infrastructure in developing countries and the increase in the number of colonoscopy procedures performed in developed countries are some of the factors that support the expansion of this segment of applications.
The Americas dominate the worldwide market for endoscopy devices due to the presence of a strong economic situation, considerable development in the field of health, and the concentration of research institutes in technology updating. for new and advanced diagnostic and treatment methods. Additionally, advanced hospital infrastructure and the availability of trained healthcare professionals are driving market expansion. Europe ranks second in the market on the basis of the escalating importance given to the rapid diagnosis and treatment of cancer and gastrointestinal diseases, changes in lifestyle and the escalating prevalence of cancer among the geriatric population. According to the Organization for Economic Cooperation and Development (OECD), Germany spent 11% of total GDP on healthcare in 2013, up from 10.8% in 2012, driving market expansion in this region.
Asia-Pacific is the fastest growing market due to the greater number of developing countries present in this region, for example countries like India and China. These countries promote the expansion of the health sector. Furthermore, the growing population of patients with cancer and gastrointestinal diseases in developing countries will directly increase the call for various diagnostic and treatment methods, which in turn will drive market expansion. The Middle East and Africa are predicted to have the smallest market share due to less availability of medical facilities and less health development. However, countries like Qatar and Kuwait are focusing more on the health field and developing medical facilities, which will boost the market in this region.
The major players in this market include Olympus (Japan), KARL STORZ (Germany), Stryker (US), Boston Scientific (US), Ethicon (US), Fujifilm Corporation (Japan), Medtronic (Ireland), Hoya Corporation (Japan), Richard Wolf GmbH (Germany), Smith & Nephew (UK), Cook Medical (US), and B. Braun (Germany).
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.3 Visualization Systems
5.1.4 Endoscopic Ultrasound
5.1.6 Y-o-Y Growth Analysis, By Product
5.1.7 Market Attractiveness Analysis, By Product
5.1.8 Market Share Analysis, By Product
5.2.2 GI Endoscopy
5.2.8 Y-o-Y Growth Analysis, By Application
5.2.9 Market Attractiveness Analysis, By Application
5.2.10 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Product
22.214.171.124 By Application
6.1.4 Market Attractiveness Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Application
6.1.5 Market Share Analysis 220.127.116.11 By Geographical Area
18.104.22.168 By Product
22.214.171.124 By Application
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.3 KARL STORZ
8.5 Boston Scientific
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures